Clinical Trial Update: Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating efficacy and safety of 1% glycopyrronium bromide topical cream for primary axillary hyperhidrosis, including long-term …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axillary Hyperhidrosis

Drugs mentioned

• glycopyrronium bromide topical cream (1%) (glycopyrronium bromide)

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Primary Axillary Hyperhidrosis | Phase 3 | Status: COMPLETED